Spondyloarthritis I- non therapeutic EULAR 2024: Do Not Miss – Spondyloarthritis I – non-therapeutic 8 Jun 2024 Olivier Fakih Olivier is a rheumatology fellow at the Department of Rheumatology of Besançon University Hospital in France. His research interests include the epidemiology of inflammatory rheumatic diseases, in particular mortality and comorbidities…
ACR Highlights… ACR Convergence Highlights 2023 – Spondyloarthritis I: Clinical (non-therapeutic) 9 Dec 20239 Dec 2023 Author: Olivier Fakih Michel et al. (2222) compared patients with a SpA + IBD codiagnosis versus those with only one diagnosis in a retrospective monocentric study. 62 patients with a…
ACR Congress Do Not Miss… ACR Convergence 2023: Do Not Miss – Spondyloarthritis II – Therapeutic 6 Nov 2023 Diego BenaventDiego is a consultant rheumatologist at Hospital de Bellvitge, Barcelona. Aside from his activities regarding healthcare technology, his major interests are spondyloarthritis, patient-reported outcomes and musculoskeletal epidemiology. Diego the…
Spondyloarthritis… Spondyloarthritis I – Non-therapeutic 29 May 202330 May 2023 Tania Gudu Tania is a Rheumatology Consultant at Ipswich Hospital, UK where she leads the Spondyloarthritis service. Her main research interests are spondyloarthritis/ psoriatic arthritis, patient reported outcomes and MSK…